Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 213

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

West Nile Virus–associated Flaccid Paralysis

Open access
Sejvar, James J., Bode, Amy V., Marfin, Anthony A., Campbell, Grant L., Ewing, David, Mazowiecki, Michael, Pavot, Pierre V., Schmitt, Joseph, Pape, John, Biggerstaff, Brad J., Petersen, Lyle R.·2005·Emerging Infectious Diseases

Abstract

The causes and frequency of acute paralysis and respiratory failure with West Nile virus (WNV) infection are incompletely understood.During the summer and fall of 2003, we conducted a prospective, population-based study among residents of a 3-county area in Colorado, United States, with developing WNV-associated paralysis.Thirtytwo patients with developing paralysis and acute WNV infection were identified.Causes included a poliomyelitislike syndrome in 27 (84%) patients and a Guillain-Barré-like syndrome in 4 (13%); 1 had brachial plexus involvement alone.The incidence of poliomyelitislike syndrome was 3.7/100,000.Twelve patients (38%), including 1 with Guillain-Barré-like syndrome, had acute respiratory failure that required endotracheal intubation.At 4 months, 3 patients with respiratory failure died, 2 remained intubated, 25 showed various degrees of improvement, and 2 were lost to followup.A poliomyelitislike syndrome likely involving spinal anterior horn cells is the most common mechanism of WNV-associated paralysis and is associated with significant short-and long-term illness and death. A cute paralysis associated with West Nile virus (WNV)infection (1-8) has been attributed to Guillain-Barré syndrome (3), a poliomyelitislike syndrome (2,4-6,8), and a generalized myeloradiculitis (1,7).Several reports have described acute respiratory failure occurring with WNVassociated paralysis (5,7).However, the frequency of acute paralysis in WNV neuroinvasive disease remains unknown, and the clinical features of WNV-associated respiratory weakness have not been characterized.During 2003, Colorado experienced an epidemic of human WNV disease; 2,947 cases were reported to the US Centers for Disease Control and Prevention (CDC) that included 621 neuroinvasive cases and 63 deaths.Acute paralysis was seen in many patients, and in several, acute respiratory failure developed that required emergent intubation.We conducted a population-based assessment of WNV-infected persons in whom acute paralysis developed to describe the clinical features, mechanisms, and shortterm outcomes. MethodsDuring the summer and fall of 2003, we identified patients with acute weakness and WNV infection from among the populations of Boulder, Larimer, and Weld counties (combined population ≈724,000) in northern Colorado by active case-finding.We were notified of suspected cases by infection control practitioners and health professionals at 8 hospitals in and around the catchment area and through ongoing state-based surveillance.A suspected case of WNV-associated weakness was defined as muscle weakness in a person of at least 1-point decrement on manual muscle testing by using the Medical Research Council (London, UK) 1-5 scale (see online Appendix Figure 1, available at http://www.cdc.gov/ncidod/EID/vol11no07/04-0991-appG1.htm), respiratory failure requiring intubation that developed <48 hours after presentation, or both.All patients had IgM antibodies detected in acute-phase serum samples by IgM antibody-capture enzyme-linked immunosorbent assay at the Colorado Department of Health Services and Environment (9,10).Remaining acute-phase serum samples from 26 patients were tested by plaque-reduction neutralization assays for antibodies to WNV and St. Louis encephalitis virus at CDC (9,10).All had WNV-specific neutralizing antibody titers ≥1:10, which were at least 4-fold greater than those for St. Louis encephalitis virus.Patients were approached under the auspices of a public health event, and oral consent was obtained.Results of West Nile Virus-associated Flaccid Paralysis

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3201/eid1107.040991

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 213

Metadata

Authors
Sejvar, J. J., Bode, A. V., Marfin, A. A., Campbell, G. L., Ewing, D., Mazowiecki, M., Pavot, P. V., Schmitt, J., Pape, J., Biggerstaff, B. J., & Petersen, L. R.
Venue
Emerging Infectious Diseases
Published
2005-07
Volume
11
Issue
7
Pages
1021-1027
ISSN
  • 1080-6040 (ISSN-L)
  • 1080-6059
OpenAlex
W2035851939
Cited by
213
References
1
FWCI
10.03
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: West Nile Virus–associated Flaccid Paralysis. https://app.cochat.ai/papers/10.3201/eid1107.040991
The paper
Sejvar, J. J., Bode, A. V., Marfin, A. A., Campbell, G. L., Ewing, D., Mazowiecki, M., Pavot, P. V., Schmitt, J., Pape, J., Biggerstaff, B. J., & Petersen, L. R. (2005). West Nile Virus–associated Flaccid Paralysis. Emerging Infectious Diseases. https://doi.org/10.3201/eid1107.040991

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.